レイノー病治療の世界市場（～2026年）

• 英文タイトル：Global Raynauds Disease Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04462
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料はレイノー病治療のグローバル市場について調査・分析したレポートです。種類別（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別レイノー病治療の競争状況、市場シェア
・世界のレイノー病治療市場：種類別市場規模 2015年-2020年（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）
・世界のレイノー病治療市場：種類別市場規模予測 2021年-2026年（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）
・世界のレイノー病治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他）
・世界のレイノー病治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他）
・北米のレイノー病治療市場分析：米国、カナダ
・ヨーロッパのレイノー病治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのレイノー病治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のレイノー病治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのレイノー病治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Allergan Plc、Apricus Biosciences, Inc.、Bayer AG、Covis Pharmaceuticals, Inc.、Human Stem Cells Institute
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Raynauds Disease Treatment Market
The global Raynauds Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Raynauds Disease Treatment Scope and Market Size
Raynauds Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Raynauds Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Allergan Plc
Apricus Biosciences, Inc.
Bayer AG
Covis Pharmaceuticals, Inc.
Human Stem Cells Institute
…

Market segment by Type, the product can be split into
Acetylcysteine
Alprostadil
ELS-140
Neovasculgen
Nitroglycerin
Others
Market segment by Application, split into
Hospital
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Raynauds Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Raynauds Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Acetylcysteine
1.4.3 Alprostadil
1.4.4 ELS-140
1.4.5 Neovasculgen
1.4.6 Nitroglycerin
1.4.7 Others
1.5 Market by Application
1.5.1 Global Raynauds Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Raynauds Disease Treatment Market Perspective (2015-2026)
2.2 Global Raynauds Disease Treatment Growth Trends by Regions
2.2.1 Raynauds Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Raynauds Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Raynauds Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Raynauds Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Raynauds Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Raynauds Disease Treatment Players by Market Size
3.1.1 Global Top Raynauds Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Raynauds Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Raynauds Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Raynauds Disease Treatment Market Concentration Ratio
3.2.1 Global Raynauds Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Raynauds Disease Treatment Revenue in 2019
3.3 Raynauds Disease Treatment Key Players Head office and Area Served
3.4 Key Players Raynauds Disease Treatment Product Solution and Service
3.5 Date of Enter into Raynauds Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Raynauds Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Raynauds Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Raynauds Disease Treatment Market Size by Application (2015-2020)
5.2 Global Raynauds Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Raynauds Disease Treatment Market Size (2015-2020)
6.2 Raynauds Disease Treatment Key Players in North America (2019-2020)
6.3 North America Raynauds Disease Treatment Market Size by Type (2015-2020)
6.4 North America Raynauds Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Raynauds Disease Treatment Market Size (2015-2020)
7.2 Raynauds Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Raynauds Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Raynauds Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Raynauds Disease Treatment Market Size (2015-2020)
8.2 Raynauds Disease Treatment Key Players in China (2019-2020)
8.3 China Raynauds Disease Treatment Market Size by Type (2015-2020)
8.4 China Raynauds Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Raynauds Disease Treatment Market Size (2015-2020)
9.2 Raynauds Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Raynauds Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Raynauds Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Raynauds Disease Treatment Market Size (2015-2020)
10.2 Raynauds Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Raynauds Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Raynauds Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Raynauds Disease Treatment Market Size (2015-2020)
11.2 Raynauds Disease Treatment Key Players in India (2019-2020)
11.3 India Raynauds Disease Treatment Market Size by Type (2015-2020)
11.4 India Raynauds Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Raynauds Disease Treatment Market Size (2015-2020)
12.2 Raynauds Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Raynauds Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Raynauds Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Allergan Plc
13.1.1 Allergan Plc Company Details
13.1.2 Allergan Plc Business Overview
13.1.3 Allergan Plc Raynauds Disease Treatment Introduction
13.1.4 Allergan Plc Revenue in Raynauds Disease Treatment Business (2015-2020))
13.1.5 Allergan Plc Recent Development
13.2 Apricus Biosciences, Inc.
13.2.1 Apricus Biosciences, Inc. Company Details
13.2.2 Apricus Biosciences, Inc. Business Overview
13.2.3 Apricus Biosciences, Inc. Raynauds Disease Treatment Introduction
13.2.4 Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2015-2020)
13.2.5 Apricus Biosciences, Inc. Recent Development
13.3 Bayer AG
13.3.1 Bayer AG Company Details
13.3.2 Bayer AG Business Overview
13.3.3 Bayer AG Raynauds Disease Treatment Introduction
13.3.4 Bayer AG Revenue in Raynauds Disease Treatment Business (2015-2020)
13.3.5 Bayer AG Recent Development
13.4 Covis Pharmaceuticals, Inc.
13.4.1 Covis Pharmaceuticals, Inc. Company Details
13.4.2 Covis Pharmaceuticals, Inc. Business Overview
13.4.3 Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Introduction
13.4.4 Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2015-2020)
13.4.5 Covis Pharmaceuticals, Inc. Recent Development
13.5 Human Stem Cells Institute
13.5.1 Human Stem Cells Institute Company Details
13.5.2 Human Stem Cells Institute Business Overview
13.5.3 Human Stem Cells Institute Raynauds Disease Treatment Introduction
13.5.4 Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2015-2020)
13.5.5 Human Stem Cells Institute Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Raynauds Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Raynauds Disease Treatment Revenue
Table 3. Ranking of Global Top Raynauds Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Raynauds Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Acetylcysteine
Table 6. Key Players of Alprostadil
Table 7. Key Players of ELS-140
Table 8. Key Players of Neovasculgen
Table 9. Key Players of Nitroglycerin
Table 10. Key Players of Others
Table 11. Global Raynauds Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Raynauds Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Raynauds Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Raynauds Disease Treatment Market Share by Regions (2015-2020)
Table 15. Global Raynauds Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Raynauds Disease Treatment Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Raynauds Disease Treatment Market Growth Strategy
Table 21. Main Points Interviewed from Key Raynauds Disease Treatment Players
Table 22. Global Raynauds Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 23. Global Raynauds Disease Treatment Market Share by Players (2015-2020)
Table 24. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynauds Disease Treatment as of 2019)
Table 25. Global Raynauds Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Raynauds Disease Treatment Product Solution and Service
Table 28. Date of Enter into Raynauds Disease Treatment Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 31. Global Raynauds Disease Treatment Market Size Share by Type (2015-2020)
Table 32. Global Raynauds Disease Treatment Revenue Market Share by Type (2021-2026)
Table 33. Global Raynauds Disease Treatment Market Size Share by Application (2015-2020)
Table 34. Global Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 35. Global Raynauds Disease Treatment Market Size Share by Application (2021-2026)
Table 36. North America Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 38. North America Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 39. North America Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 40. North America Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 41. North America Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 42. Europe Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 44. Europe Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 46. Europe Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 48. China Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 49. China Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 50. China Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 51. China Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 52. China Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 53. China Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 54. Japan Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 56. Japan Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 58. Japan Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 62. Southeast Asia Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 64. Southeast Asia Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 66. India Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 67. India Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 68. India Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 69. India Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 70. India Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 71. India Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Raynauds Disease Treatment Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Raynauds Disease Treatment Market Share (2019-2020)
Table 74. Central & South America Raynauds Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Raynauds Disease Treatment Market Share by Type (2015-2020)
Table 76. Central & South America Raynauds Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Raynauds Disease Treatment Market Share by Application (2015-2020)
Table 78. Allergan Plc Company Details
Table 79. Allergan Plc Business Overview
Table 80. Allergan Plc Product
Table 81. Allergan Plc Revenue in Raynauds Disease Treatment Business (2015-2020) (Million US$)
Table 82. Allergan Plc Recent Development
Table 83. Apricus Biosciences, Inc. Company Details
Table 84. Apricus Biosciences, Inc. Business Overview
Table 85. Apricus Biosciences, Inc. Product
Table 86. Apricus Biosciences, Inc. Revenue in Raynauds Disease Treatment Business (2015-2020) (Million US$)
Table 87. Apricus Biosciences, Inc. Recent Development
Table 88. Bayer AG Company Details
Table 89. Bayer AG Business Overview
Table 90. Bayer AG Product
Table 91. Bayer AG Revenue in Raynauds Disease Treatment Business (2015-2020) (Million US$)
Table 92. Bayer AG Recent Development
Table 93. Covis Pharmaceuticals, Inc. Company Details
Table 94. Covis Pharmaceuticals, Inc. Business Overview
Table 95. Covis Pharmaceuticals, Inc. Product
Table 96. Covis Pharmaceuticals, Inc. Revenue in Raynauds Disease Treatment Business (2015-2020) (Million US$)
Table 97. Covis Pharmaceuticals, Inc. Recent Development
Table 98. Human Stem Cells Institute Company Details
Table 99. Human Stem Cells Institute Business Overview
Table 100. Human Stem Cells Institute Product
Table 101. Human Stem Cells Institute Revenue in Raynauds Disease Treatment Business (2015-2020) (Million US$)
Table 102. Human Stem Cells Institute Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Raynauds Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Acetylcysteine Features
Figure 3. Alprostadil Features
Figure 4. ELS-140 Features
Figure 5. Neovasculgen Features
Figure 6. Nitroglycerin Features
Figure 7. Others Features
Figure 8. Global Raynauds Disease Treatment Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Raynauds Disease Treatment Report Years Considered
Figure 13. Global Raynauds Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Raynauds Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Raynauds Disease Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Raynauds Disease Treatment Market Share by Players in 2019
Figure 18. Global Top Raynauds Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynauds Disease Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Raynauds Disease Treatment Revenue in 2019
Figure 20. North America Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Raynauds Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed

以下、関連資料のご紹介

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

クッシング病治療の世界市場（～2026年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11540 2020年11月25日 99Pages
当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...

ニューカッスル病治療の世界市場（～2026年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03968 2020年11月20日 99Pages
当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

感染症治療の世界市場（～2026年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12367 2020年11月25日 91Pages
当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

人獣共通感染症治療の世界市場（～2026年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY05134 2020年11月20日 93Pages
当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

ポンペ病治療の世界市場（～2026年）

Global Pompe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04326 2020年11月20日 95Pages
当調査資料はポンペ病治療のグローバル市場について調査・分析したレポートです。種類別（乳児期発症ポンペ病、成人発症ポンペ病）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

ベーチェット病治療の世界市場（～2026年）

Global Behcet Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11034 2020年11月25日 98Pages
当調査資料はベーチェット病治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

メニエール病治療の世界市場（～2026年）

Global Meniere's Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12649 2020年11月25日 98Pages
当調査資料はメニエール病治療のグローバル市場について調査・分析したレポートです。種類別（投薬、非侵襲的治療・手順、中耳注射、手術、その他）市場規模、用途別（病院、クリニック、医学研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

キャッスルマン病治療の世界市場（～2026年）

Global Castleman Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11288 2020年11月25日 93Pages
当調査資料はキャッスルマン病治療のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、化学療法、放射線療法、免疫療法、コルチコステロイド、抗ウイルス薬）市場規模、用途別（病院、臨床、外来診療ユニット）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリ...

希少神経疾患治療の世界市場（～2026年）

Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04460 2020年11月20日 98Pages
当調査資料は希少神経疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…
クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
ベーチェット病治療の世界市場（～2026年） Behcet disease, also called Behcet's syndrome, is a rare disorder that causes blood vessel inflammation throughout your body. Market Analysis and Insights: Global Behcet Disease Treatment Market The global Behcet Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX…
ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…
ウィルソン病治療の世界市場（～2026年） Market Analysis and Insights: Global Wilson's Disease Treatment Market The global Wilson's Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Wilson's Disease Treatment Scope and Market Size Wilson's Dis…